Tissue pharmacokinetics of daptomycin measured by in vivo microdialysis in patients with diabetic foot infectio

Conditions: A group of adult male or female patients with documented diabetes and bacterial soft tissue infection of the foot who must be subjected to undergo intravenous antimicrobial therapy with broad spectrum antibiotics.

Registration Number: EUCTR2008-006949-75-AT

Lead Sponsor: Medical University Graz, Department for Plastic Surgery

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Recruiting

Sex: All

Target Recruitment: 10

Inclusion Criteria

1. Written informed consent to participate in the study.
2. Male or female patient of 18 years of age or older.
3. Patient suffers from documented diabetes and soft tissue infection of the lower limb.
4. Requires intravenous broad-spectrum anti-microbial therapy
5. CRP higher than 5 mg/dl at baseline
6. Patient has no relevant renal dysfunction indicated by a creatinine clearance =40 ml/min as determined by the Cockcroft-Gault equation using actual body weight
7. Negative urine pregnancy test in females of childbearing potential
8. Patient is willing to participate in the study, follow protocol study treatment regimen, and comply with all planned assessments.

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1. Treatment with the study drug within the past three weeks prior to study enrolment.
2. Site of infection other than infection of the lower limb
3. History of hypersensitivity to the study drug
4. Patients submitted to the hospital with known pathogens resistant to study drug.
5. Patient with a neutrophils count <1000/mm3.
6. Use of any other investigational therapy at the time of enrolment, or within 30 days or 5 half-lives before inclusion into, whichever is longer.
7. Patients unable or unwilling to adhere to the study-designated procedures and restrictions.
8. Unable to understand the nature, purpose and extent of the study
9. Nursing women

Study & Design

Study Type: Interventional clinical trial of medicinal product

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: -To evaluate the pharmacokinetic profile of daptomycin in inflamed subcutaneous adipose tissue in diabetic foot infection at steady state after once daily intravenous administration of 6 mg/kg.;Secondary Objective: - To evaluate the pharmacokinetic profiles of daptomycin in non-inflamed subcutaneous adipose tissue and in plasma<br><br>- To compare the pharmacokinetic profiles of daptomycin in inflamed soft tissue, healthy soft tissue, and plasma <br>;Primary end point(s):

Secondary Outcome Measures